Anti-Aging Blemish Control Peel Pads

Description

No specific information related to the Description section for SPL code 34089-3 is provided in the text.

Uses and Indications

This drug is indicated for the treatment, control, and prevention of acne.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

On clean, dry skin, the applicator should be smoothed over the affected area, taking care to avoid contact with the eyes. Treatment should begin with one application daily. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two times daily if necessary.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once a day or every other day. Following application, it is advised to apply a moisturizer and sunscreen during the day to enhance skin hydration and protection.

Contraindications

Use is contraindicated in patients who experience excessive skin irritation, as continued use may exacerbate the condition. In such cases, discontinuation of the product and consultation with a healthcare professional is advised. Additionally, the product should not come into contact with the eyes, as this may lead to adverse effects.

Warnings and Precautions

For external use only. It is imperative that this product is not ingested. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

General precautions must be observed to ensure safety. This product should be kept out of reach of children to prevent accidental ingestion.

In the case of excessive skin irritation or if irritation worsens, it is essential to discontinue use immediately and consult a healthcare professional for further evaluation and guidance.

Side Effects

For external use only. Patients should be advised that if excessive skin irritation develops or increases, they should discontinue use and consult a doctor.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one topical acne medication unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and skin health.

Packaging & NDC

Below are the non-prescription pack sizes of Anti-Aging Blemish Control Peel Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

The product has not been specifically studied in pregnant patients, and no explicit warnings or precautions regarding its use during pregnancy are provided in the prescribing information. There are no stated safety concerns, dosage modifications, or special precautions related to the use of this product in pregnant individuals. Additionally, no contraindications in pregnancy have been mentioned. Healthcare professionals should consider the absence of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no specific warnings or recommendations concerning the use of this product during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as per established protocols. Additionally, contacting a poison control center can provide valuable guidance on the management of overdose cases.

Documentation of the incident, including the substance involved, the amount ingested, and the time of ingestion, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that if they experience excessive skin irritation that develops or worsens, they should discontinue use of the product and consult a healthcare professional.

It is important to discuss with patients the potential for increased dryness or irritation of the skin when using this product in conjunction with other topical acne medications. Patients should be instructed to use only one medication at a time unless otherwise directed by a healthcare provider.

Additionally, patients should be cautioned to avoid contact with their eyes while using this product.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should advise patients to discontinue use and consult a doctor if excessive skin irritation develops or increases. Additionally, patients are encouraged to follow up with a moisturizer and sunscreen during the day to maintain skin health.

Drug Information (PDF)

This file contains official product information for Anti-Aging Blemish Control Peel Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)